IL6 and Obesity: This disruption not only impacts the adipogenic capacity but may also contribute to the proangiogenic features of obesity-derived APCs, as seen in their increased IL-6 expression and activation of Notch signaling pathways, further linking chronic inflammation to adipose tissue dysfunction [40].